Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.93 Insider Own0.90% Shs Outstand76.45M Perf Week-9.09%
Market Cap1.59B Forward P/E205.07 EPS next Y0.10 Insider Trans-2.82% Shs Float75.76M Perf Month6.78%
Income-68.18M PEG- EPS next Q-0.03 Inst Own108.48% Short Float5.80% Perf Quarter-11.71%
Sales375.47M P/S4.24 EPS this Y92.86% Inst Trans0.34% Short Ratio6.09 Perf Half Y-20.37%
Book/sh14.64 P/B1.42 EPS next Y239.22% ROA-5.78% Short Interest4.39M Perf Year-19.81%
Cash/sh2.74 P/C7.60 EPS next 5Y- ROE-6.20% 52W Range18.61 - 30.52 Perf YTD-24.39%
Dividend Est.- P/FCF60.39 EPS past 5Y-10.52% ROI-6.05% 52W High-31.85% Beta1.70
Dividend TTM- Quick Ratio4.69 Sales past 5Y34.42% Gross Margin62.24% 52W Low11.77% ATR (14)0.86
Dividend Ex-Date- Current Ratio5.00 EPS Y/Y TTM-122.18% Oper. Margin-1.42% RSI (14)45.52 Volatility3.19% 4.22%
Employees815 Debt/Eq0.01 Sales Y/Y TTM20.66% Profit Margin-18.16% Recom1.89 Target Price29.83
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q77.79% Payout- Rel Volume0.64 Prev Close20.84
Sales Surprise3.74% EPS Surprise87.42% Sales Q/Q17.50% EarningsMay 07 AMC Avg Volume721.03K Price20.80
SMA20-2.31% SMA50-0.33% SMA200-12.16% Trades Volume460,681 Change-0.19%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Reiterated Needham Buy $30 → $33
Jan-18-23Downgrade Raymond James Outperform → Mkt Perform
Jan-05-23Initiated Scotiabank Sector Outperform $33
Jan-07-22Initiated Stephens Overweight $52
Nov-18-21Resumed Goldman Buy $60
Jun-15-21Initiated Raymond James Outperform $45
Feb-18-21Resumed Needham Buy $88
Jan-28-21Initiated Truist Buy $61
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $48
Sep-09-20Initiated Morgan Stanley Underweight $35
May-23-24 10:00AM
May-22-24 04:05PM
May-21-24 09:59AM
May-15-24 05:04PM
May-13-24 09:55AM
03:13PM Loading…
May-08-24 03:13PM
May-07-24 10:55PM
May-06-24 04:05PM
Apr-22-24 05:00PM
08:30AM Loading…
Apr-16-24 08:30AM
Apr-02-24 10:33AM
Feb-27-24 05:55PM
Feb-26-24 03:20PM
Feb-23-24 11:10AM
Feb-22-24 06:05PM
Feb-21-24 05:00PM
Feb-08-24 08:00AM
Feb-06-24 08:15AM
08:00AM Loading…
Jan-08-24 08:00AM
Dec-12-23 04:30PM
Dec-01-23 04:05PM
Nov-29-23 08:30AM
Nov-22-23 08:30AM
Nov-08-23 04:39PM
Nov-07-23 04:57PM
Nov-02-23 08:15AM
Oct-27-23 08:30AM
Oct-26-23 02:50PM
Oct-17-23 08:15AM
Oct-16-23 10:43AM
Oct-12-23 09:00AM
Oct-04-23 04:05PM
Sep-28-23 04:05PM
Sep-27-23 09:00AM
Sep-21-23 04:05PM
Sep-07-23 04:05PM
Sep-06-23 08:15AM
Sep-02-23 06:15AM
Aug-29-23 08:15AM
Aug-22-23 08:15AM
Aug-15-23 04:15PM
Aug-08-23 06:05PM
Aug-01-23 08:15AM
Jul-19-23 05:00PM
Jul-08-23 08:43PM
Jun-20-23 08:31AM
Jun-12-23 08:31AM
May-30-23 06:56AM
May-25-23 05:13PM
May-24-23 09:00AM
May-23-23 05:00PM
May-22-23 07:30AM
May-12-23 06:15AM
May-05-23 01:59PM
May-04-23 06:25PM
May-03-23 05:44PM
May-02-23 04:05PM
May-01-23 05:35PM
Apr-29-23 04:31PM
Apr-27-23 04:05PM
Apr-18-23 09:48AM
Apr-17-23 08:30AM
Apr-13-23 05:00PM
Apr-12-23 08:30AM
Mar-23-23 06:54AM
Mar-15-23 04:15PM
Mar-11-23 12:11PM
Mar-10-23 09:30AM
Feb-27-23 05:00PM
Feb-24-23 05:42AM
Feb-22-23 06:15PM
Feb-15-23 08:36AM
Feb-13-23 05:23PM
Feb-06-23 05:00PM
Feb-01-23 04:05PM
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EASTHAM KARINDirectorApr 01 '24Option Exercise13.1910,000131,90043,125Apr 02 04:17 PM
EASTHAM KARINDirectorApr 01 '24Sale21.6510,000216,52833,125Apr 02 04:17 PM
JONES EVAN/ FADirectorMar 01 '24Option Exercise13.1910,000131,90047,601Mar 05 05:28 PM
JONES EVAN/ FADirectorMar 01 '24Sale24.3610,000243,59937,601Mar 05 05:28 PM
JONES EVAN/ FADirectorJul 19 '23Sale30.173,09093,23235,173Jul 24 05:06 PM
JONES EVAN/ FADirectorJul 19 '23Sale30.1483825,25737,601Jul 24 05:06 PM
BISHOP JOHN LDirectorJul 18 '23Option Exercise6.3710,00063,70043,125Jul 19 08:35 PM
BISHOP JOHN LDirectorJul 18 '23Sale30.5010,000305,00033,125Jul 19 08:35 PM
JONES EVAN/ FADirectorJul 18 '23Sale30.197,441224,61638,263Jul 19 08:33 PM
JONES EVAN/ FADirectorJul 18 '23Sale30.162,32470,09038,439Jul 19 08:33 PM
BISHOP JOHN LDirectorJul 17 '23Option Exercise6.3710,00063,70043,125Jul 19 08:35 PM
JONES EVAN/ FADirectorJul 17 '23Sale30.0723,949720,10645,704Jul 19 08:33 PM
JONES EVAN/ FADirectorJul 17 '23Sale30.0719,095574,10640,763Jul 19 08:33 PM
BISHOP JOHN LDirectorJul 17 '23Sale30.0010,000300,00233,125Jul 19 08:35 PM
Bhanji MunaDirectorJun 16 '23Sale26.445,893155,78628,514Jun 21 04:55 PM
Bhanji MunaDirectorMay 30 '23Sale25.911,53939,87524,733Jun 01 05:06 PM